NASDAQ: SBFM
Sunshine Biopharma Inc Stock Forecast, Predictions & Price Target

Analyst price target for SBFM

Based on 1 analyst offering 12 month price targets for Sunshine Biopharma Inc

Min Forecast
$15.00+1,062.79%
Avg Forecast
$15.00+1,062.79%
Max Forecast
$15.00+1,062.79%

Should I buy or sell SBFM stock?

Based on 1 analyst offering ratings for Sunshine Biopharma Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SBFM stock forecasts and price targets.

SBFM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-12-05

1 of 1

SBFM vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
SBFM$1.29$15.00+1,062.79%Strong Buy
EVOK$2.33N/AN/A
SNOA$2.22N/AN/A
PRFX$2.10N/AN/A
SXTC$1.02N/AN/A

Sunshine Biopharma Stock Forecast FAQ

Is Sunshine Biopharma Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SBFM) stock is to Strong Buy SBFM stock.

Out of 1 analyst, 1 (100%) are recommending SBFM as a Strong Buy, 0 (0%) are recommending SBFM as a Buy, 0 (0%) are recommending SBFM as a Hold, 0 (0%) are recommending SBFM as a Sell, and 0 (0%) are recommending SBFM as a Strong Sell.

If you're new to stock investing, here's how to buy Sunshine Biopharma stock.

What is SBFM's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SBFM price target, the average SBFM price target is $15.00, with the highest SBFM stock price forecast at $15.00 and the lowest SBFM stock price forecast at $15.00.

The Wall Street analyst predicted that Sunshine Biopharma's share price could reach $15.00 by Dec 5, 2025. The average Sunshine Biopharma stock price prediction forecasts a potential upside of 1,062.79% from the current SBFM share price of $1.29.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.